Related Experiment Video
Updated: Jun 16, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene
M D Pinho1, J Melo-Cristino, M Ramirez
1Instituto de Microbiologia, Faculdade de Medicina Lisboa, Universidade de Lisboa, Lisbon, Portugal.
Abstract:
Quinolone resistance is an emerging problem in Streptococcus pyogenes, and recombination with Streptococcus dysgalactiae DNA has been implicated as a frequent mechanism leading to resistance. We have characterized a collection of S. dysgalactiae subsp. equisimilis isolates responsible for infections in humans (n = 314) and found a high proportion of levofloxacin-resistant isolates (12%). Resistance was associated with multiple emm types and genetic lineages, as determined by pulsed-field gel electrophoretic profiling. Since we could not find evidence for a role of efflux pumps in resistance, we sequenced the quinolone resistance-determining regions of the gyrA and parC genes of representative resistant and susceptible isolates. We found much greater diversity among the parC genes (19 alleles) than among the gyrA genes (5 alleles). While single mutations in either GyrA or ParC were sufficient to raise the MIC so that the strains were classified as intermediately resistant, higher-level resistance was associated with mutations in both GyrA and ParC. Evidence for recombination with S. pyogenes DNA was found in some parC alleles, but this was not exclusively associated with resistance. Our data support the existence of a common reservoir of genes conferring quinolone resistance shared between S. dysgalactiae subsp. equisimilis and S. pyogenes, while no recombination with the animal pathogen S. dysgalactiae subsp. dysgalactiae could be found.
Insights
Quinolone resistance in Streptococcus dysgalactiae is linked to genetic mutations. Recombination between Streptococcus dysgalactiae and Streptococcus pyogenes may share resistance genes, impacting human infections.
Area of Science:
- Microbiology
- Genetics
- Antimicrobial Resistance
Background:
- Quinolone resistance is a growing concern in Streptococcus pyogenes infections.
- Genetic recombination between Streptococcus dysgalactiae and Streptococcus pyogenes is suspected as a key mechanism for resistance.
- Streptococcus dysgalactiae subspecies equisimilis causes human infections.
Purpose of the Study:
- To investigate levofloxacin resistance in Streptococcus dysgalactiae subsp. equisimilis.
- To identify genetic mechanisms underlying quinolone resistance in this species.
- To explore potential gene sharing between S. dysgalactiae and S. pyogenes.
Main Methods:
- Characterization of 314 S. dysgalactiae subsp. equisimilis isolates.
- Pulsed-field gel electrophoresis for genetic profiling.
- Sequencing of gyrA and parC genes to identify mutations.
Main Results:
- 12% of isolates exhibited levofloxacin resistance, linked to diverse emm types and lineages.
- No evidence for efflux pump involvement in resistance.
- High diversity in parC alleles (19) compared to gyrA alleles (5).
- Single gyrA or parC mutations conferred intermediate resistance; dual mutations led to higher resistance.
- Recombination with S. pyogenes DNA observed in some parC alleles, but not solely linked to resistance.
Conclusions:
- A shared reservoir of quinolone resistance genes likely exists between S. dysgalactiae subsp. equisimilis and S. pyogenes.
- No evidence of recombination with S. dysgalactiae subsp. dysgalactiae was found.
- Genetic mutations in gyrA and parC are critical for quinolone resistance development.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance